Have a personal or library account? Click to login
From Stenosis to Restenosis - The New Coronary Artery Disease Continuum in the PCI Era Cover

From Stenosis to Restenosis - The New Coronary Artery Disease Continuum in the PCI Era

Open Access
|Oct 2020

References

  1. 1. WHO -Cardiovascular Diseases fact sheet
  2. 2. Jennings S, Bennett K, Shelley E, Kearney P, Daly K, Fennell W. Trends in percutaneous coronary intervention and angiography in Ireland, 2004-2011: Implications for Ireland and Europe. Int J Cardiol Heart Vessel. 2014;4:35-39. Published 2014 Aug 12. doi:10.1016/j.ijchv. 2014.08.00110.1016/j.ijchv.2014.08.001
  3. 3. Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305(16):1677-1684. doi:10.1001/jama.2011.52210.1001/jama.2011.522
  4. 4. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-371.10.1161/01.CIR.77.2.361
  5. 5. Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K, Kaitani K, Inoue K, Nakagawa Y, Yokoi H, Iwabuchi M, Hamasaki N, Nosaka H, Nobuyoshi M. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation. 2002 Jun 25;105(25):2986-2991.10.1161/01.CIR.0000019743.11941.3B
  6. 6. Cassese S, Byrne RA, Schulz S, et al. Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting. Eur Heart J 2015;36:94-9. 10.1093/eurheartj/ehu38310.1093/eurheartj/ehu383
  7. 7. Fishman RF, Kuntz RE, Carrozza JP, Jr, et al. Long-term results of directional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol 1992;20:1101-10. 10.1016/0735-1097(92)90365-T10.1016/0735-1097(92)90365-T
  8. 8. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-2310.1056/NEJMoa03507114523139
  9. 9. Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150-E1162. doi:10.21037/jtd. 2016.10.9310.21037/jtd
  10. 10. Hong SJ, Kim MH, Ahn TH, Ahn YK, Bae JH, Shim WJ, Ro YM, Lim DS. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart. 2006 Aug;92(8):1119-1124.10.1136/hrt.2005.075960186112516449516
  11. 11. Garg S, Räber L, Serruys PW, Windecker S. Coronary artery stents.In Percutaneous Interventional Cardiovascular Medicine The PCR-EAPCI Textbook.Volume II.Part III. Chapter 3. Percutaneous interventions for cardiovascular disease. PCR Publishing 2012:50-144
  12. 12. Lee MS, Pessegueiro A, Zimmer R, Jurewitz D, Tobis J. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J Invasive Cardiol. 2008 Aug;20(8):401-403.
  13. 13. Rathore S, Kinoshita Y, Terashima M, Katoh O, Matsuo H, Tanaka N, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T. A comparison of clinical presentations, angiographic patterns and outcomes of instent restenosis between bare metal stents and drug eluting stents. EuroIntervention. 2010 Feb;5(7):841-846.10.4244/EIJV5I7A14120142201
  14. 14. Lin LY, Hwang JJ. Clinical evaluation, Electrocardiography, Holter Monitoring. In: intoiu IC, Popma JJ, Bae HJ, Rivard A, Galassi AR, Cristian G. Coronary stent restenosis. The Publishing House of the Romanian Academy. Bucharest, 2011: 363-369
  15. 15. De Labriolle A, Bonello L, Lemesle G, Steinberg DH, Roy P, Xue Z, Kaneshige K, Suddath WO, Satler LF, Kent KM, Pichard AD, Lindsay J, Waksman R. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar;102(3):209-21710.1016/j.acvd.2009.01.00419375675
  16. 16. Ruygrok PN, Webster MW, de Valk V, van Es GA, Ormiston JA, Morel MA, Serruys PW. Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention. Circulation. 2001;104:2289-2294.10.1161/hc4401.09829411696467
  17. 17. Buchanan GL, Basavarajaiah S, Chieffo A. Stent Thrombosis: Incidence, Predictors and New Technologies. Thrombosis. 2012;2012:956-962.10.1155/2012/956962332967922577541
  18. 18. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation.2007;115:2344-2351.10.1161/CIRCULATIONAHA.106.68531317470709
  19. 19. Garzon P P, Eisenberg MJ. Functional testing for the detection of restenosis after percutaneous transluminal coronary angioplasty: a meta-analysis. Can J Cardiol. 2001 Jan;17(1):41-48.
  20. 20. Taylor AJ, Cerqueira M, Hodgson JB, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56(22):1864-1894.10.1016/j.jacc.2010.07.00521087721
  21. 21. Izzo P, Macchi A, De Gennaro L, Gaglione A, Di Biase M, Brunetti ND. Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options. Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):158-169.10.1177/2048872612449111376052324062904
  22. 22. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, Lemesle G, Torguson R, Kineshige K, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R. Outcome differences with the use of drug-eluting stents for the treatment of instent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15;1(03(4):491-495.10.1016/j.amjcard.2008.09.10719195508
DOI: https://doi.org/10.2478/inmed-2020-0125 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 61 - 68
Published on: Oct 14, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Alice Elena Munteanu, Liviu Chiriac, Filip Romi Bolohan, Daniel Niţă, Corina Diaconescu, Iulia Theodora Ioniţă, Mihnea Casian, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.